Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Growth Metrics
Income Statement
Others
Ratios

Indivior Pharmaceuticals (INDV) Net Income (2022 - 2026)

Indivior Pharmaceuticals has reported Net Income over the past 5 years, most recently at $89.0 million for Q1 2026.

  • For Q1 2026, Net Income rose 85.42% year-over-year to $89.0 million; the TTM value through Mar 2026 reached $251.0 million, up 3685.71%, while the annual FY2025 figure was $210.0 million, 2900.0% up from the prior year.
  • Net Income for Q1 2026 was $89.0 million at Indivior Pharmaceuticals, down from $102.0 million in the prior quarter.
  • Over five years, Net Income peaked at $102.0 million in Q4 2025 and troughed at -$329.0 million in Q4 2022.
  • A 5-year average of $6.9 million and a median of $55.0 million in 2024 define the central range for Net Income.
  • Biggest five-year swings in Net Income: plummeted 438.81% in 2023 and later surged 385.71% in 2025.
  • Year by year, Net Income stood at -$329.0 million in 2022, then skyrocketed by 120.67% to $68.0 million in 2023, then tumbled by 69.12% to $21.0 million in 2024, then surged by 385.71% to $102.0 million in 2025, then decreased by 12.75% to $89.0 million in 2026.
  • Business Quant data shows Net Income for INDV at $89.0 million in Q1 2026, $102.0 million in Q4 2025, and $42.0 million in Q3 2025.